Conjugated pneumococcal vaccine versus polysaccharide pneumococcal vaccine for prevention of pneumonia and invasive pneumococcal disease in immunocompetent and immunocompromised adults and children-Reference-Cited by-同舟云学术

Conjugated pneumococcal vaccine versus polysaccharide pneumococcal vaccine for prevention of pneumonia and invasive pneumococcal disease in immunocompetent and immunocompromised adults and children

Published:2019-02-20 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Golos Miri¹,Eliakim-Raz Noa²,Stern Anat³,Leibovici Leonard⁴,Paul Mical³

Affiliation:

1. Rambam Health Care Campus; ICU; Ha-aliya 8 St Haifa Israel 33705

2. Beilinson Hospital, Rabin Medical Center; Department of Medicine E; and Sackler Faculty of Medicine, Tel-Aviv University, Israel; 39 Jabotinski Street Petah Tikva Israel 49100

3. Rambam Health Care Campus; Division of Infectious Diseases; Ha-aliya 8 St Haifa Israel 33705

4. Beilinson Hospital, Rabin Medical Center; Department of Medicine E; Kaplan Street Petah Tikva Israel 49100

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012306.pub2/epdf/full

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High diversity within and low but significant genetic differentiation among geographic and temporal populations of the global Streptococcus pneumoniae;Canadian Journal of Microbiology;2024-06-01

2. Antimicrobial resistance of Streptococcus pneumoniae from invasive pneumococcal diseases in Latin American countries: a systematic review and meta-analysis;Frontiers in Public Health;2024-01-22

3. Convergent impact of vaccination and antibiotic pressures on pneumococcal populations;Cell Chemical Biology;2023-12

4. Non-Invasive Vaccines: Challenges in Formulation and Vaccine Adjuvants;Pharmaceutics;2023-08-09

5. Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting;Cost Effectiveness and Resource Allocation;2023-08-09